USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3

Devaraj E, Perumal E, Subramaniyan R, Mustapha N. Liver fibrosis: extracellular vesicles mediated intercellular communication in perisinusoidal space. Hepatology. 2022;76:275–285

PubMed  Google Scholar 

Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–218

CAS  PubMed  PubMed Central  Google Scholar 

Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14:397–411

CAS  PubMed  Google Scholar 

Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. 2012;56:1171–1180

PubMed  Google Scholar 

Senoo H, Kojima N, Sato M. Vitamin A-storing cells (stellate cells). Vitam Horm. 2007;75:131–159

CAS  PubMed  Google Scholar 

Iwaisako K, Jiang C, Zhang M, Cong M, Moore-Morris TJ, Park TJ, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A. 2014;111:E3297-3305

CAS  PubMed  PubMed Central  Google Scholar 

Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2021;18:151–166

PubMed  Google Scholar 

Park JS, Ma H, Roh YS. Ubiquitin pathways regulate the pathogenesis of chronic liver disease. Biochem Pharmacol. 2021;193: 114764.

CAS  PubMed  Google Scholar 

Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159–192

CAS  PubMed  Google Scholar 

Zhang JL, Du BB, Zhang DH, Li H, Kong LY, Fan GJ, et al. OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways. Hepatology. 2022;75:1218–34.

CAS  PubMed  Google Scholar 

Ning Z, Guo X, Liu X, Lu C, Wang A, Wang X, et al. USP22 regulates lipidome accumulation by stabilizing PPARgamma in hepatocellular carcinoma. Nat Commun. 2022;13:2187

CAS  PubMed  PubMed Central  Google Scholar 

Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, et al. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv Sci (Weinh). 2023;10: e2302953

PubMed  Google Scholar 

Li X, Yang G, Zhang W, Qin B, Ye Z, Shi H, et al. USP13: multiple functions and target inhibition. Front Cell Dev Biol. 2022;10: 875124

PubMed  PubMed Central  Google Scholar 

Fang X, Zhou W, Wu Q, Huang Z, Shi Y, Yang K, et al. Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination. J Exp Med. 2017;214:245–67.

CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Li Z, Xiao H, Xie B, He J, Song M, et al. Usp13 deficiency impairs autophagy and facilitates age-related lung fibrosis. Am J Respir Cell Mol Biol. 2023;68:49–61

CAS  PubMed  Google Scholar 

Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12:325–38.

CAS  PubMed  Google Scholar 

Yuan Y, Li Y, Wu X, Bo J, Zhang L, Zhang J, et al. POH1 induces Smad3 deubiquitination and promotes lung cancer metastasis. Cancer Lett. 2024;582: 216526.

CAS  PubMed  Google Scholar 

Yuan S, Wang Z, Yao S, Wang Y, Xie Z, Wang J, et al. Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fraction. Theranostics. 2024;14:5793–5808

CAS  PubMed  PubMed Central  Google Scholar 

Ma C, Wang D, Tian Z, Gao W, Zang Y, Qian L, et al. USP13 deubiquitinates and stabilizes cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation. Oncogene. 2023;42:2249–2262

CAS  PubMed  PubMed Central  Google Scholar 

Zhang P, Wang PX, Zhao LP, Zhang X, Ji YX, Zhang XJ, et al. The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nat Med. 2018;24:84–94

CAS  PubMed  Google Scholar 

Luo P, Qin C, Zhu L, Fang C, Zhang Y, Zhang H, et al. Ubiquitin-specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6. Hepatology. 2018;68:1786–803.

CAS  PubMed  Google Scholar 

Zhou B, Luo Y, Bi H, Zhang N, Ma M, Dong Z, et al. Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11. Cell Metab. 2024;36(2228–2244): e2227

Google Scholar 

Zhao J, Bai J, Peng F, Qiu C, Li Y, Zhong L. USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. Cell Death Dis. 2023;14:40

CAS  PubMed  PubMed Central  Google Scholar 

Xu F, Liu C, Zhou D, Zhang L. TGF-beta/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016;64:157–167

CAS  PubMed  PubMed Central  Google Scholar 

Sinha A, Iyengar PV, Ten Dijke P. E3 Ubiquitin Ligases: Key Regulators of TGFbeta Signaling in Cancer Progression. Int J Mol Sci 2021;22.

Chen N, Balasenthil S, Reuther J, Killary AM. DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity. Cancer Res. 2014;74:5683–5689

CAS  PubMed  PubMed Central  Google Scholar 

Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, et al. Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell. 2001;12:1431–43.

CAS  PubMed  PubMed Central  Google Scholar 

Herhaus L, Al-Salihi M, Macartney T, Weidlich S, Sapkota GP. OTUB1 enhances TGFbeta signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat Commun. 2013;4: 2519.

PubMed  Google Scholar 

Galant C, Marchandise J, Stoenoiu MS, Ducreux J, De Groof A, Pirenne S, et al. Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor beta. Rheumatology (Oxford). 2019;58:708–718

CAS  PubMed  Google Scholar 

Xu M, Tan J, Zhu L, Ge C, Dong W, Dai X, et al. The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway. Acta Pharm Sin B. 2023;13:1071–1092

CAS  PubMed  Google Scholar 

Lai Q, Li W, Hu D, Huang Z, Wu M, Feng S, et al. Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles. J Control Release. 2024;376:601–17.

CAS  PubMed  Google Scholar 

Huang J, Huang H, Wang Y, Xu B, Lin M, Han S, et al. Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation. Biomaterials. 2023;299: 122134

CAS  PubMed  Google Scholar 

Zhou Z, Feng Y, Jiang M, Yao Z, Wang J, Pan F, et al. Ionizable polymeric micelles (IPMs) for efficient siRNA delivery. Nat Commun. 2025;16:360

CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif